Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

CEC levels may be a useful marker for predicting prostate cancer progression.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Certain natural compounds called terpenes may help prevent prostate cancer.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Gene variation affects prostate issues and hair loss.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

A new method accurately measures nine specific hormones in human blood.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.